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Abstract
Object To assess the feasibility of magnetization transfer
(MT) imaging of the bowel wall in patients with Crohn’s
disease (CD), and to evaluate its utility for the detection of
intestinal fibrosis.
Materials and methods In this prospective study, 31
patients (age 39.0 ± 13.2 years) with CD were examined
in a 1.5T MR scanner. To establish a standard of reference,
two independent readers classified the patients in different
disease states using standard MR enterography, available
clinical data and histological findings. In addition to the
standard protocol, a 2D gradient-echo sequence (TR/TE
32 ms/2.17 ms; flip angle 25) with/without 1,100 Hz off-
resonance prepulse was applied. MT ratios (MTR) of the
small bowel wall were computed off-line on a pixel-
by-pixel basis.
Results The MT sequences acquired images of sufficient
quality and spatial resolution for the evaluation of the small
bowel wall without detrimental motion artefacts. In normal
bowel wall segments, an intermediate MTR of 25.4 ±
3.4 % was measured. The MTR was significantly increased
in bowel wall segments with fibrotic scarring (35.3 ±
4.0 %, p \ 0.0001). In segments with acute inflammation,
the mean MTR was slightly smaller (22.9 ± 2.2 %).
Conclusion MT imaging of the small bowel wall is feasible
in humans with sufficient image quality and may help with the
identification of fibrotic scarring in patients with CD.
Keywords Magnetization transfer contrast imaging 
Crohn disease  Fibrosis
Introduction
Crohn’s disease (CD) often exhibits a patchy pattern of
bowel affection with intact bowel segments interspersed
with short inflamed segments (‘‘skip lesions’’). Complica-
tions of the chronic inflammation are formation of fistu-
lae, abscesses and intestinal strictures, associated with
abdominal pain, nausea and vomiting which may lead to
small bowel obstruction. A stenosis may be caused by
acute inflammation leading to mucosal swelling or chronic
fibrosis due to scarring. The distinction of the two aetiol-
ogies is of critical importance for the management of CD
patients. Acute inflammation may well be treated with
anti-inflammatory medication such as corticosteroids,
or anti-bodies against tumor necrosis factor (TNF) (e.g.,
infliximab, adalimumab or certolizumab pegol). However,
these drugs may have severe adverse effects; thus, any
inappropriate application, for example, in case of fibrosis-
induced stenosis needs to be avoided. The only treatment
option for severe fibrotic strictures or stenoses remains
surgery. A decision for surgery should not be made too late
as complication rates (e.g., anastomosis leakage) are higher
when an emergency situation (e.g., acute bowel obstruc-
tion) is apparent. In contrast, timely elective surgery based
on reliable imaging would have the best outcome.
Standard MR enterography (MRE) protocols for the
evaluation of small bowel structures include steady state
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free precession sequences, T2-weighted fast spin-echo
sequences and spoiled T1-weighted 3D encoded gradient-
echo sequences for post-contrast imaging [1]. Recently, as
an additional contrast mechanism, magnetization transfer
(MT) was proposed for detection of bowel fibrosis in
Crohn’s disease [2]. MT imaging attempts to quantify the
extent of MT between hydrogen nuclei in mobile envi-
ronments, predominantly in ‘‘free’’ water molecules, and
hydrogen nuclei in more slowly reorienting environments,
predominantly covalently or non-covalently bound to
macromolecules. The exchange process involves chemical
exchange of protons and/or through-space dipole–dipole
cross-relaxation. The MT effect grows with the number
of hydrogen nuclei that switch from a high-mobility
environment, such as in a free water molecule, to a low-
mobility environment, such as, for example, in a hydroxyl
group bound to a macromolecule. Thus, the effect size
represents a rather indirect measure of the concentrations
of corresponding macromolecules, for example, proteins,
such as collagen, in an aqueous physiological environment.
To observe and measure it, two gradient-echo data sets are
typically acquired, with and without application of an off-
resonant prepulse that saturates the low-mobility proton
pool of hydrogen nuclei and results in a net signal loss. The
relative signal intensities in the two data sets allow cal-
culation of the MT ratio (MTR), which is characteristic for
a given tissue and the chosen sequence parameters [3].
In an animal study using Lewis rats with subserosally
injected peptidoglycan-polysaccharide (PG-PS) for devel-
opment of bowel inflammation, Adler et al. [2] found a
good correlation between the MTR and the tissue fibrosis
as well as collagen content 28 days post-injection.
The aim of our study was to assess the feasibility of MT
imaging of the bowel wall in patients with CD, and to
evaluate its utility for the detection of intestinal fibrosis.
Materials and methods
Patients
This prospective study was approved by the local Ethics
committee. All patients gave written informed consent to
the MR examination as well as to the scientific evaluation
of the data sets. We consecutively included 31 patients
older than 18 years (10 women, 21 men; mean age 39.0 ±
13.2 years; range 18–73 years; mean BMI 22.6 ± 4.8 kg/m2;
range 14.9–34.6 kg/m2) with known (n = 29) or suspected
CD (n = 2), and an indication for a MR imaging (MRI)
examination of the small bowel (Table 1). The patients
were recruited and scanned between December 2010
and February 2012. Exclusion criteria were typical con-
traindications to MR imaging (MR incompatible metal
implants, pacemakers, cochlear implants, claustrophobia,
etc.).
MR scanner
All MR studies were performed on a 1.5 Tesla MRI unit
(Philips Achieva, Philips Healthcare, Best, The Netherlands)
using a phased-array coil with 16 anterior and 16 posterior
elements. The MR scanner was equipped with Dual Quasar
Gradients (slewrate 180 mT m-1 ms-1, maximal gradient
strength 33 mT/m).
Imaging protocol
Patient preparation included fasting of at least 4 h before
the MR examination. 1,000 ml of oral contrast medium
(2.5 % mannitol solution) was ingested by the patient over
a period of 1 h prior to imaging for a better distension of
the bowel lumen [4, 5]. Additionally, the patients received
a water enema (400–600 ml) immediately before the pro-
cedure provided they had consented to this previously.
Bowel paralysis was induced by twofold intravenous
injection of 10 mg scopolamine butyl bromide (Buscopan,
Bo¨hringer Ingelheim, Biberach, Germany), the first time
before the start of the imaging and the second time just
before the contrast-medium application.
The individual parameters of each imaging sequence
are displayed in Table 2. The imaging protocol started
with gradient-echo localizers in all 3 orientations. Axial
and coronal 2D-encoded single-shot T2w fast spin-echo
sequences, a 2D coronal steady state free precession
(SSFP) sequence, a 3D coronal and a 2D axial T1-weighted
gradient-echo sequence were acquired for visualization of
bowel morphology.
For MT imaging, two different imaging sequences were
tested: a 3D gradient-echo sequence (4 patients; Table 1
patient 1–4) and a 2D gradient-echo sequence (27 patients;
Table 1 patient 5–31). Each sequence was acquired 2 times,
with and without the off-resonance MT preparation pre-
pulse. For both sequences, the off-resonance prepulse had a
Gaussian shape with a frequency offset of 1,100 Hz, a
maximum effective B1 field of 15.7 lT, a duration of
1,502 ls, an effective flip angle of 620 and a bandwidth of
399 Hz. The pool of the low-mobility protons shows a fast
relaxation; therefore, MT prepulses have to be applied with
high frequency to achieve sufficient saturation. The shortest
possible TR including a MT prepulse of 32 ms was applied
in the both MT sequences. Excitation angles were chosen
relatively small to keep the influence of the MT prepulse on
the tissue equilibrium magnetization as large as possible.
After intravenous bolus injection of 0.1 mmol/kg body
weight of Gd-DOTA (Dotarem, Guerbet, Paris, France) at
an injection rate of 2 ml/s, a coronal T1-weighted
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fat-suppressed 3D gradient-echo sequences and an axial
T1-weighted 2D gradient-echo sequence with water
selective excitation were acquired.
Data evaluation
The magnetization transfer ratio (MTR) is a quantitative
measure of the interaction between the low and high-
mobility proton pools in a given tissue, as assessed with a
given acquisition. MTR is defined as [3]
MTR ¼ SI0  SISAT
SI0
where SI0 and SISAT refer to the image intensity without
and with the saturation prepulse, respectively. From the
data sets, the MTR values were calculated pixelwise with
custom-made computer scripts written in the programming
language Matlab (The Mathworks, Inc., Natick, MA).
In the, thus, obtained MTR maps, the MTR was quantified
by region-of-interest (ROI) analysis. MTR values were
determined for skeletal muscle, cartilage tissue, renal
Table 1 Patients data and MTR values of the measured bowel wall
Patient Gender Age Diagnosis Clinical activity Disease state Main localization Stenosis/
stricture
MTR-n
(%)
MTR-p
(%)
Dj j difference
(%)
R1 R2 R1 R2
1 M 37 CD ? ? A ? C A ? C Terminal ileum Yes *
2 F 23 CD ?? ? A ? C A ? C Terminal ileum No *
3 M 34 IC ? ?? A ? C A ? C Sigma/rectum Yes *
4 M 49 CD ?? ?? C C Terminal ileum No *
5 M 18 CD/CMV ??? ??? A A Colon Yes N/A 20.7 /
6 M 33 CD ? ? C C Terminal ileum No 26.7 30.4 3.72
7 F 35 CD ??? ??? A ? C A ? C Terminal ileum Yes 20.2 40.6 20.34
8 M 28 CD ??? ??? A ? C A ? C Terminal ileum Yes 17.7 41.7 24.01
9 M 37 CD ?? ? C C Terminal ileum No 23.2 27.6 4.39
10 M 48 CD ?? ?? C C Terminal ileum No 25.6 36.6 11.05
11 M 45 CD ?? ??? A ? C A ? C Terminal ileum Yes 27.1 38.7 11.63
12 M 24 CD ?? ?? A ? C A ? C Terminal ileum Yes 26.5 37.4 10.92
13 F 18 CD ??? ?? A A Terminal ileum Yes 17.3 22.9 5.6
14 F 37 CD ?? ? C A ? C Terminal ileum Yes 27.2 32.0 4.72
15 F 48 CD ? ? A ? C A ? C Terminal ileum No 23.7 N/A /
16 M 46 s. CD – - - - N/A No 25.1 N/A /
17 F 52 CD ?? ? C C Sigma/rectum No 27.8 39.1 11.31
18 F 55 CD - - - - N/A No 25.5 N/A /
19 M 29 CD ??? ??? A ? C A ? C Ileum Yes 30.9 38.1 7.21
20 F 66 CD ?? ? C C Ileum Yes 31.5 28.7 2.77
21 M 73 s. CD - - - - N/A No 25.2 N/A /
22 M 47 CD ?? ?? C C Colon No 23 33.1 10.15
23 M 30 CD ?? ?? A ? C A ? C Terminal ileum Yes 26.2 34.5 8.27
24 M 31 CD ??? ??? C A ? C Terminal ileum Yes 28.6 33.4 4.82
25 F 39 CD - - - - N/A No 23.7 N/A /
26 M 47 CD - - - - N/A No N/A N/A /
27 F 35 CD ?? ?? A ? C A ? C Terminal ileum Yes 29.2 38.0 8.83
28 M 56 CD ? ? A ? C C Terminal ileum Yes 26.3 38.5 12.2
29 M 34 CD ?? ?? C A ? C Sigma/rectum Yes 25.7 32.5 6.8
30 M 26 CD ?? ?? A A Terminal ileum Yes 24.8 25.0 0.2
31 M 29 CD ? ? A ? C A ? C Terminal ileum Yes 26.5 34.7 8.2
Diagnosis: Crohn’s disease (CD), suspected CD (s. CD), Cytomegalovirus (CMV), indeterminate collitis (IC); Clinical activity: ‘‘-’’no disease
activity, ‘‘?’’ low activity, ‘‘??’’ moderate activity, ‘‘???’’ high activity; Disease state: ‘‘A’’ acute and active inflammatory disease state, ‘‘C’’
chronic fibrostenotic disease state, ‘‘A ? C’’ transitional forms with both acute- and chronic-fibrotic changes possibly with fistula and stenosis.
Magnetization transfer ratio of morphologically normal bowel wall (MTR-n) and of pathologically altered bowel wall (MTR-p) as well as the
difference between these values if provided. Reader one (R1); reader two (R2); ‘‘*’’ patients with 3D magnetization transfer gradient-echo
sequence
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cortex and liver parenchyma as a reference, as well as from
non-affected small bowel and from pathologically altered
bowel structures, which were identified in the standard
imaging protocols. At least 4 ROIs were positioned for
each tissue. Mean MTR were obtained by averaging all
ROI measurements from each tissue and each patient.
Great care was taken to avoid partial volume effects. The
ROIs were defined freeform in areas in which the bowel
wall could clearly be identified. Bowel segments with
insufficient distension or with intraluminal food debris
were excluded from the analysis. ROI sizes were typically
between 12 and 50 mm2 for the non-affected small bowel
wall, between 25 and 100 mm2 for the pathologically
altered bowel and between 68 and 500 mm2 for the refer-
ence tissues. All ROI measurements in the MTR maps were
made by the same author (S.P. with more than 3 years of
experience in MR imaging).
Clinical grading
All patients with pathologically altered bowel were clas-
sified in different disease states by two independent readers
(A.B. and N.C., with 9 and 4 years of experience in
abdominal MRI, respectively) based on previously descri-
bed classifications [6–8]. ‘‘A’’ acute and active inflamma-
tory disease state; ‘‘C’’ chronic fibrostenotic disease state
and ‘‘A ? C’’ transitional forms with both acute- and
chronic-fibrotic changes possibly with fistula and stenosis
(Table 3). To distinguish between acute- and chronic-
fibrotic disease as well as between stenosis due to acute
inflammation or due to fibrosis, the readers used all
acquired MRI sequences and available histological findings
(n = 13). ‘‘A’’ acute and active inflammatory disease state
was defined as an acute inflammation of the bowel wall
(bowel wall thickening [3 mm) with nodular, polypoid or
asymmetric intestinal thickening, high mural signal inten-
sity on T2w fat-saturated images, layered pattern of
enhancement, imbibition of the surrounding fat tissue and
histological findings with signs of an acute inflammation.
‘‘C’’ chronic fibrostenotic disease state was assigned in
patients with stricturing disease behavior, bowel obstruc-
tion due to fibrotic-stenotic changes, fixed narrowing of the
affected segment with hypointense signal in T1w and T2w
sequences, inhomogeneous contrast enhancement and no
evidence of edema or surrounding mesenteric inflammation
[6–8]. If the findings showed criteria for both disease states
‘‘A’’ and ‘‘C,’’ then the readers assigned these patients as
transitional forms ‘‘A ? C’’. Moreover, all patients were
classified in a clinical score-scale for determination of the
clinical activity at the time of the MR examination
(Table 3). Based on a previously described classification of
CD activity [9], we divided the patients in 4 different stage-
related groups: ‘‘-’’no disease activity; ‘‘?’’ low activity;
‘‘??’’ moderate activity; ‘‘???’’ high activity. For
grading of the disease activity, all available clinical data
from the patient records were used such as weight loss,
clinical symptoms at presentation, CRP (C-reactive
Protein) values in the blood serum and fecal calprotectin
Table 2 MRI sequence parameters
MRI sequence parameters
Parameter T2w FSE ax T2w FSE cor SSFP cor MT GRE ax MT GRE ax T1w GRE cor T1w GRE ax
Encoding 2D 2D 2D 2D 3D 3D 2D
Field-of-view (mm) 300 9 227 400 9 400 400 9 376 395 9 282 380 9 302 400 9 400 375 9 309
Image matrix 248 9 187 248 9 220 268 9 266 196 9 141 252 9 201 204 9 201 204 9 139
Slice thickness (mm) 4 7 4 4 4 4 7
Intersection spacing (mm) 4.4 1 3 0 0 0 1
Voxel size (mm) 1.2 9 1.2 1.6 9 1.8 1.5 9 1.5 2.0 9 2.0 1.5 9 1.5 2.0 9 2.0 1.8 9 2.2
Echo time (ms) 80 80 2.1 2.2 4.6 2 4.9
Echo train length/TFE factor 67 78 132 – – 47 –
Repetition time (m) 459.8 444.2 4.2 32 32 4.3 259.3
Flip angle () 90 90 90 25 15 10 70
Averages 1 2 1 1 2 2 2
Bandwidth (Hz/px) 760.8 677.7 1275.7 385.1 161.3 375.6 351.4
No. of slices 46 25 34 10 50 75 50
Fat suppression SPAIR SPAIR No No No SPAIR ProSet
Respiratory control BH BH BH BH Free B BH BH
Acquisition time 0:21 0:11 0:19 0:25 2:40 0:21 0:32
Ax axial, Cor coronal, FSE fast spin echo, SSFP steady state free precession, MT magnetization transfer, GRE gradient-echo, BH breath hold, free
B free breathing, SPAIR spectral selection attenuated inversion recovery, ProSet principle of selective excitation technique
294 Magn Reson Mater Phy (2013) 26:291–301
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values. Furthermore, typical patterns of disease activity as
found in the standard MRI data sets were considered as
well (such as bowel wall thickening, mucosal or submu-
cosal edema, imbibition of the surrounding fat tissue,
lymph node enlargement, pattern and degree of contrast-
medium uptake as well as bowel obstruction or abscess).
Statistical evaluation
Reader agreement was assessed by Cohen’s kappa coeffi-
cient. Kappa values of 0.01–0.4 were considered to indicate
slight or fair agreement, 0.41–0.6 moderate agreement,
0.61–0.8 substantial agreement and values higher than 0.81
almost perfect agreement [10]. Other results are reported as
mean ± standard deviation. The data was descriptively
reviewed and statistically tested for normality with the
Kolmogorov–Smirnov test. P values were calculated by
using the Student’s t test for paired samples. A
p value \0.05 was considered significant. All statistical
analyses were performed using commercially available
software (SPSS, version 19.0, Chicago, IL, USA). For the
estimation of the optimal cutoff of the MTR values for
detection of bowel fibrosis, we used a receiver operating
characteristic (ROC) curve [11]. The optimal cutoff was
defined as the value at which the sum of the sensitivity and
specificity was maximized.
Results
Grading of the patients with clinical findings/
conventional MR enterography
Five of the 31 included patients had completely normal MR
findings of the small and large bowel. The remaining
26 patients presented pathological imaging features typical
of chronic inflammatory bowel disease. Three of these
patients showed acute inflammation of the bowel wall
(Table 1, patient 5, 13 and 30). Patient five was simulta-
neously affected by Cytomegalovirus associated colitis.
The other 23 patients had chronic-fibrotic inflammation
with or without an additional feature of acute disease.
Reader one assigned ten patients to the chronic-fibrotic
disease state, and 13 to the group with additional acute
inflammation. The second reader ranked eight and 15 in the
respective groups. The reader agreement was almost per-
fect (j value of 0.81). In four patients (Table 1, patient 14,
24, 28 and 29), the reader classification showed a
discrepancy. In consensus reading, these patients were
considered to have both acute and chronic-fibrotic changes,
as one of the readers detected characteristics for both dis-
ease states. From the 26 patients with pathological bowel
alterations, five had changes of the colon (including sigma T
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and rectum) (Table 1, patient 3, 5, 17, 22 and 29). In the
other 21 patients, the small intestine was affected (pre-
dominantly the terminal ileum; n = 19). One of the
patients with chronic and acute inflammation of the colon
was finally diagnosed with indeterminate colitis (Table 1,
patient 3) instead CD, while all other patients had the
diagnosis of CD. Stenosis or stricture of the bowel wall was
found in the MR images of 18 patients.
From the 26 patients with pathological features, reader
one assigned 6, 14 and 6 patients to the high, moderate and
low disease activity groups, respectively. The second
ranked 6, 10 and 10 patients in the respective groups. The
inter-reader agreement was substantial with a j value of
0.65.
Image quality of the MT sequences
The 3D gradient-echo sequence with an acquisition time of
2:40 min per data set, which we evaluated in the first four
patients, showed strong magnetization transfer effects
(Fig. 1a). Although the patients were asked for shallow
breathing during the scan, significant motion artefacts could
not be avoided. These artefacts hampered the quantitative
analysis, particularly since they were more evident in the
subtraction images for MT quantification. These patients
were excluded from the quantitative data evaluation. The 2D
MT sequence that we finally included in the MRE protocol
was acquired during breath hold (acquisition time 25 s) and
provided images free of breathing artefacts (Fig. 1b). The
rather long acquisition time of 25 s was well tolerated by the
young patient population. Furthermore, no relevant bowel
movement artefacts were noted in the subtraction images. In
contrast to the 3D sequence, minor opposed-phase artefacts
were visible at the interface between bowel wall and peri-
toneal fat, which, however, did not hamper the image
analysis. In all volunteers, image quality was sufficient to
identify pathologically altered bowel segments if present,
based on the conventional MRE protocol. The MTR map of
only one of the patients (Table 1, patient 26) had to be
excluded from quantitative analysis due to body movement
between the two acquisitions.
Quantitative evaluation of MTR
In the quantitative evaluation of the 2D MT sequence, we
measured high MTR values in reference tissues known to
exhibit high MT: skeletal muscle tissue 49.9 ± 1.2 %
(n = 27) (psoas muscle and the erector spinae muscle) and
cartilage 62.3 ± 6.2 % (n = 9) (intervertebral disk). In the
parenchyma of the abdominal organs, somewhat lower
MTR values were measured: renal cortex 31.1 % ± 2.0;
n = 6 and liver 38.7 %; n = 1. In the normal, unaffected
bowel wall segments of the patients diagnosed with fibrosis
based on the standard MRI protocol, a mean MTR of
Fig. 1 Typical images acquired with the 3D and 2D encoding
scheme are displayed, a data set with 3D encoding, b data set
acquired with 2D encoding technique. Left column images acquired
with MT prepulse, middle column without application of the MT
prepulse, right column corresponding MTR map with a color scale
in %. Comparing both acquisition schemes, it is clearly visible that
the 3D data set exhibits stronger breathing artefacts compared to the
2D acquisition. The artefacts of the 3D encoding become even more
pronounced in the MTR maps
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26.1 ± 3.4 % (range 17.7–31.5 %; n = 18) was measured.
In contrast, the mean MTR in the fibrosed segments of
the same patients was significantly higher with 35.3 ±
4.0 % (range 27.6–41.7 %; n = 18) (p \ 0.0001) (Table 4;
Fig. 2) with a mean paired difference of 9.7 ± 5.6 %
(range 2.8–24.0 %). The mean MTR of bowel segments
with acute inflammation was slightly lower (22.9 ± 2.2 %;
range 20.7–25.0 %; n = 3) compared to healthy bowel
wall structures (25.0 ± 3.7 %; range 17.3–31.5 %; n = 25)
(Table 4; Figs. 2, 3). This difference was, however, not
statistically significant (p = 0.3) (Fig. 4).
The measured MTR values of the bowel wall (n = 46;
25 non-altered bowel wall, 18 chronic-fibrotic segments
and three acute inflamed segments) demonstrated sufficient
power for identification of fibrotic segments (area under the
ROC curve (AUC) 0.98 ± 0.01; 95 % CI). The optimal
cutoff was at MTR = 28.7 % with a sensitivity of 95 %
and a specificity of 90 %.
Discussion
Our study demonstrates that MT imaging of small bowel
structures is feasible in a clinical setting with sufficiently
high image quality for a quantitative assessment. Chronic-
fibrotic strictures exhibited higher MTR compared to non-
affected bowel wall. In contrast, in bowel segments with
acute inflammatory stenosis, the MTR was similar to nor-
mal bowel wall or even slightly lower. To our knowledge,
this is the first study that reports MT ratios for the bowel
wall in human subjects affected by CD. The proposed
technique might facilitate the differentiation of fibrotic
strictures and acute inflammatory stenosis of the bowel
wall in patients with CD, which has a strong impact on the
treatment planning for these patients. Due to the short
acquisition time of the 2D MT sequence, it can easily be
implemented in a standard MRE protocol.
Our results are in excellent concordance with the find-
ings of an animal study from Adler et al. [2], in which, for
the first time, MT imaging was suggested for assessment of
bowel wall fibrosis in CD. In this study, a relevant increase
in the MTR (24.7 ± 1.9 %) in fibrotic segments of bowel
wall in rats with PG-PS-induced intestinal fibrosis (a rat
model of CD) was reported compared to a control group
(10.8 ± 1.7 %) [2]. Adler et al. could demonstrate that the
increase in MTR correlated with the grade of fibrosis
(microscopically assessed as a histologic fibrosis score by
two gastrointestinal pathologists blinded to the MR results)
and with the amount of type I collagen, which was densi-
tometrically measured. Since the MTR values depend
on many data-acquisition parameters (such as the encod-
ing mode (2D or 3D), the pre-saturation technique and
parameters, the phase-encode order and corresponding
k-space filling, the voxel size, the field strength, etc.) the
results from Adler et al. could not quantitatively be com-
pared with the results of our study.
We measured the MTR in pathologically altered bowel
wall of patients with CD and compared them in an intra-
individual comparison with mean MTR values in normal
bowel segments. All imaging parameters (such as field-
of-view, matrix size and repetition time) were kept con-
stant to standardize the MT protocol as far as possible.
The MTR values of different MT sequences cannot
directly be compared, however, if all sequence parame-
ters are kept constant the MT ratios are a quantitative
measure appropriate for meaningful inter-individual
comparisons.
A higher MTR value implies a larger amount of mag-
netization exchanged between the proton pools of low and
high mobility in a tissue, due to, for example, a higher
overall rate of exchange or to a larger pool of low-mobility
protons. Possible explanations for our findings are (1) an
increase in the concentration of collagen fibers in fibrotic
tissue, like collagen type I, which was shown in the animal
study from Adler et al. and which is known to bind a large
number of water molecules or (2) a hyperplasia of the
muscularis externa, which was also diagnosed in the animal
study of Adler et al. in the fibrotic rat models and which
may also lead to higher MTR values. The data in our
current study do not provide a basis for an estimate of the
relative weights of these potential mechanisms to the
observed increase in the MTR values in the pathologically
fibrotic bowel segments.
The transverse magnetization in the low-mobility proton
pool relaxes rapidly with short time constants in the order
of *100 ls or even shorter, which results in homoge-
neously broadened resonance lines with widths of thou-
sands of Hertz. It is thus possible to selectively saturate the
system of the low-mobility proton pool. As a consequence,
polarization and magnetization will be transferred to the
pool of highly mobile protons, which dominantly contrib-
utes to the signal observed with standard medical imaging
Table 4 Magnetization transfer ratio of the measured bowel wall
Magnetization transfer ratio (MTR) as well as highest and lowest
measured values in parentheses (MTR (min/max) of chronic-fibrotic
bowel wall (fibrosis), of morphological normal bowel wall and of
acute inflammation of the bowel wall (inflammation)
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sequences, from the low-mobility pool, and, thus, the
observed signal will decrease. The transfer occurs with
rates that are in the range of the T1 relaxation times in the
low-mobility proton pool, and the effects only build up
over time periods that are not negligibly short when com-
pared with, for example, TR times. For quantitative
assessments of MTR with gradient-echo sequences and
pre-saturation pulses, this means that the sequence design
Fig. 2 T2w fat-saturated FSE images (left column), contrast-
enhanced T1w fat-saturated GRE images (middle column) and
parametrical MTR maps of the examined patients with Crohn’s
disease (right column); a a female, 18-year-old patient with acute
inflammation of the bowel wall in the terminal ileum with mucosal
and submucosal edema as well as imbibition of the surrounding fat
tissue (active inflammatory disease); MTR map shows little magne-
tization transfer in the inflammatory bowel wall; b a male, 29-year-
old patient with acute stenosis of the bowel lumen due to mucosal
edema in addition to a chronic-fibrotic stricture of the terminal Ileum
with internal fistula exhibiting high MT (chronic ? acute ulcerative
regional enteritis; fistula forming and perforating disease); c a male,
45-year-old patient with chronic stenosis and stricture in the terminal
Ileum showing high MT in the affected bowel segment (fibrostenotic
disease); d a male, 37-years-old patient with focal thickening of the
bowel wall in the terminal ileum with corresponding contrast
enhancement (arrows) as well as normal bowel loops. MTR values
are notably higher in segments with chronic-fibrotic changes
compared to the morphologically normal bowel structures. Color
scale in %
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needs to be optimized in a trade-off between the magnitude
of the observed MT effects and the acquisition time. Typ-
ically, carefully tailored 3D sequences with interleaved
saturation and imaging pulses have been found to offer a
better SNR for MTR assessments than competitive 2D
sequences. Unfortunately, the acquisition time of the 3D
sequences is in general too long to fit into a single breath
hold. In our study, we found 3D acquisitions during con-
stant shallow breathing to result in image artefacts that were
too severe to allow a meaningful quantitative assessment of
MTR values. In addition, the 3D sequence could not be
combined with synchronization techniques such as trig-
gering based on navigator or breathing-belt data.
To avoid the breathing artefacts, we resorted to a
multi-slice 2D sequence with a lower number of encod-
ing steps and slice-selective spin excitation. The slice-
selective spin excitation pulses also act as off-resonance
prepulses in other imaging slices of the same interleaved
acquisition, thereby causing an increased saturation of
the macromolecular pool even in the sequence acquired
without the MT prepulse. Therefore, a lower MTR is
expected to be obtained from the corresponding images
when compared with those from the 3D acquisition. To
sufficiently accelerate the 2D acquisition, we also had to
increase the receiving bandwidth and to use parallel
encoding techniques, which resulted in lower signal-
to-noise ratio compared to the 3D sequence. However,
we were able to show that in spite of the disadvantageous
parameter changes, image quality was sufficiently high
and the magnetization effects were large enough for a
quantitative assessment of the MTR in small bowel
segments. The observed MTR values were in good
agreement to previously reported data for reference tis-
sues such as skeletal muscle, cartilage tissue or renal
cortex [12–14]. The normalization of the MTR values to
a reference tissue might be suitable to reduce unwanted
signal variations in further studies. Minor opposed-phase
artefacts were visible in the images from the 2D MT
sequence due to a shortening of the echo time to 2.1 ms,
which we tolerated for the benefit of an increased signal-
to-noise ratio. The effect might be minimized using fat
saturation.
Our study has the following limitations:
1. The majority of patients, typical for patients undergo-
ing MRE imaging, were in the chronic phase of the
disease and showed fibrostenotic segments with a more
or less pronounced additional inflammation. We had a
relatively small number of patients with ‘‘pure’’ acute
inflammation or ‘‘pure’’ fibrosis.
2. Histopathological confirmation was not routinely
obtained. It would have been difficult to justify an
additional invasive procedure for research purposes in
this patient cohort that already underwent a great
number of clinical examinations during the course of
their disease. On the other hand, MRE is intended to
Fig. 3 Parametrical MTR maps
of the first two patients from
Fig. 2 with a smaller color map
range (0–50 %) showing in
more detail the focal MTR
changes within the bowel; a the
magnetization transfer in the
inflammatory bowel wall
approximately corresponds to a
value between 18 and 23 %,
whereas the chronic-fibrotic
stricture in b shows higher MTR
ranges between 35 and 50 %
Fig. 4 Magnetization transfer ratio in % of chronic-fibrotic bowel
wall (fibrosis), of morphologically normal bowel wall (normal) and of
acute inflamed bowel wall (inflammation) as well as of further
reference tissues (muscle, cartilage and renal cortex); number of
patients in parentheses above the corresponding bars
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avoid ileocolonoscopy in a clinical setting. It was
previously shown that MRE may serve as an alterna-
tive to endoscopy in the evaluation of the activity of
ileocolic CD with sufficient sensitivity and specificity
for assessment of bowel wall thickening, mucosal or
submucosal edema, imbibition of the surrounding fat
tissue and lymph node enlargement [7, 15–19]. A
combination of clinical symptoms; endoscopic, radio-
logical, histopathological and surgical findings as well
as laboratory parameters are taken into account for
diagnosis and therapy monitoring in CD [20]. We have
considered the revised Montreal classification of CD
[6] as well as the classification from Maglinte et al. [8]
to evaluate the current activity of the disease. Similar
to disease activity, the presence of fibrosis was not
histologically confirmed in all patients, but was
assessed based on imaging features in combination to
the clinical findings.
3. In our study, we did not evaluate if the additional
information from MT imaging would have altered
patient management, treatment decisions or outcome.
The aim of our study was to gain initial experience
with MT imaging of the bowel wall in humans and its
potential application in the assessment of bowel wall
fibrosis in CD. Future prospective studies should be
sought that include an assessment of patient outcome
depending on the additional diagnostic information
available from MT imaging in the MRE protocols of
small bowel.
4. No algorithm for image registration of the sequences
with and without MT pulse was applied. However, the
reproducibility of the bowel position between the two
subsequent sequences seemed high as we did not find
relevant motion artefacts in the MTR maps, potentially
due to the smaller bowel movement in patients with
CD compared to healthy subjects.
5. The chosen 2D MT sequence does not cover the entire
abdomen, but approximately 40–50 % in the cranio-
caudal direction. In this study, a radiologist was
present during the MR measurement to determine area
of affected bowel structures for planning of the MT
sequences. For coverage of the complete abdomen,
both, the sequence with MT preparation and the
sequence without MT preparation need to be applied
2–3 times each.
Conclusion
In conclusion, we demonstrated that MT can be measured
in the human bowel wall using a 2D encoded gradient-echo
sequence with a MT prepulse; the proposed quantitative
technique can contribute to the differentiation of fibrotic
strictures from acute inflammatory stenosis of the bowel
wall in patients with CD at the expense of only a few
minutes additional examination time.
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